Cross Country Healthcare, Inc. - Common Stock (CCRN)
7.9700
-0.1700 (-2.09%)
NASDAQ · Last Trade: Dec 9th, 11:50 AM EST
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · December 4, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 4, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · December 4, 2025

Via Benzinga · February 22, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via Benzinga · February 21, 2024
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · December 4, 2025

U.S. stock futures rose on Friday following Thursday's selloff that pushed the Nasdaq 100 index into the correction zone.
Via Benzinga · March 7, 2025

Via Benzinga · December 4, 2024

Via Benzinga · November 29, 2023

Via Benzinga · December 4, 2024

Via Benzinga · December 4, 2024

Cross Country Healthcare, Inc. shares are soaring premarket after agreeing to be acquired by Aya Healthcare for $18.61 per share in an all-cash deal valued at $615 million. The merger will expand Aya's services and create opportunities for employees.
Via Benzinga · December 4, 2024

CCRN stock results show that Cross Country Healthcare missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 31, 2024

Via Benzinga · May 2, 2024

CCRN stock results show that Cross Country Healthcare beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

Via Benzinga · February 19, 2024

Via Benzinga · February 16, 2024

Via Benzinga · November 1, 2023


